Cash Flow Statement

Currency: GBP

	Mar-2016	Sep-2016	Mar-2017	Sep-2017	Mar-2018	Sep-2018	Mar-2019	Sep-2019	Mar-2020	Sep-2020	Mar-2021	Sep-2021	Dec-2021	Mar-2022	Sep-2022	Mar-2023	Sep-2023
Operating Cash Flow
Net Income	(3)	(4)	(4)	(4)	(3)	(3)	(3)	(3)	(3)	(3)	(3)	(3)	(2)	(3)	(4)	(5)	(4)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	2	1	0	0	0	0	0	0	0	0	(0)	(0)	(0)	0	0	0	0
Cash Taxes Paid	0	(0)	(0)	(0)	(1)	(1)	(0)	(1)	(0)	(0)	(0)	(0)	(1)	(1)	(1)	(0)	(1)
Change in Working Capital	0	0	0	0	1	1	1	0	0	0	0	0	1	0	1	1	1
Cash from Operating Activities	(2) N/A	(3) -80%	(3) -14%	(3) -5%	(2) +30%	(2) +9%	(2) -7%	(2) -8%	(3) -4%	(3) -11%	(3) -3%	(3) +14%	(2) +40%	(3) -71%	(3) -13%	(4) -41%	(4) +15%
Investing Cash Flow
Capital Expenditures	(0)	(0)	(0)	(0)	(0)	(0)	0	0	(0)	(0)	(0)	(0)	0	(0)	(0)	(0)	0
Other Items	(2)	(2)	2	2	0	0	0	0	0	0	(6)	(6)	(5)	2	2	5	5
Cash from Investing Activities	(2) N/A	(2) -4%	2 N/A	2 +3%	(0) N/A	(0) +71%	0 N/A	0 N/A	(0) N/A	(0) N/A	(6) -600 400%	(6) 0%	(5) +13%	2 N/A	2 +2%	5 +203%	5 0%
Financing Cash Flow
Net Issuance of Common Stock	9	7	0	0	2	2	1	5	5	0	11	11	0	0	0	0	0
Net Issuance of Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other	0	0	0	0	0	0	0	0	(0)	0	(1)	0	0	0	0	0	0
Cash from Financing Activities	9 N/A	7 -22%	0 N/A	0 N/A	2 +8 713%	2 -1%	1 -67%	5 +673%	5 -13%	0 -98%	10 +9 263%	10 -1%	0 N/A	0 N/A	0 N/A	0 N/A	0 N/A
Change in Cash
Net Change in Cash	5 N/A	2 -64%	(1) N/A	(1) -6%	(0) +83%	(0) +79%	(2) -3 151%	3 N/A	2 -27%	(3) N/A	1 N/A	2 +19%	4 +102%	(1) N/A	(1) -29%	0 N/A	1 +119%
Free Cash Flow
Free Cash Flow	(2) N/A	(3) -82%	(3) -12%	(3) -3%	(2) +30%	(2) +9%	(2) -7%	(2) -8%	(3) -4%	(3) -11%	(3) -3%	(3) +13%	(2) +40%	(3) -71%	(3) -13%	(4) -41%	(4) +15%

Evgen Pharma PLC
LSE:EVG